Literature DB >> 12820963

Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1).

Shile Huang1, Lili Shu, Michael B Dilling, John Easton, Franklin C Harwood, Hidenori Ichijo, Peter J Houghton.   

Abstract

Under serum-free conditions, rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), induces apoptosis of cells lacking functional p53. Cells expressing wild-type p53 or p21(Cip1)arrest in G1 and remain viable. In cells lacking functional p53, rapamycin or amino acid deprivation induces rapid and sustained activation of apoptosis signal-regulating kinase 1 (ASK1), c-Jun N-terminal kinase, and elevation of phosphorylated c-Jun that results in apoptosis. This stress response depends on expression of eukaryotic initiation factor 4E binding protein 1 and is suppressed by p21(Cip1) independent of cell cycle arrest. Rapamycin induces p21(Cip1) binding to ASK1, suppressing kinase activity and attenuating cellular stress. These results suggest that inhibition of mTOR triggers a potentially lethal response that is prevented only in cells expressing p21(Cip1).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820963     DOI: 10.1016/s1097-2765(03)00180-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  72 in total

1.  Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation.

Authors:  Manish R Patel; Ahad A Sadiq; Joe Jay-Dixon; Tanawat Jirakulaporn; Blake A Jacobson; Faris Farassati; Peter B Bitterman; Robert A Kratzke
Journal:  Int J Oncol       Date:  2011-11-04       Impact factor: 5.650

Review 2.  Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons.

Authors:  Akihito Muto; Tamara N Fitzgerald; Jose M Pimiento; Stephen P Maloney; Desarom Teso; Jacek J Paszkowiak; Tormod S Westvik; Fabio A Kudo; Toshiya Nishibe; Alan Dardik
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

3.  Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.

Authors:  Brett Langley; Melissa A D'Annibale; Kyungsun Suh; Issam Ayoub; Aaron Tolhurst; Birgül Bastan; Lichuan Yang; Brian Ko; Marc Fisher; Sunghee Cho; M Flint Beal; Rajiv R Ratan
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

Review 4.  Targeting the B cell receptor pathway in chronic lymphocytic leukemia.

Authors:  Matthew S Davids; Jennifer R Brown
Journal:  Leuk Lymphoma       Date:  2012-12

5.  4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells.

Authors:  Seongseok Yun; Nicole D Vincelette; Katherine L B Knorr; Luciana L Almada; Paula A Schneider; Kevin L Peterson; Karen S Flatten; Haiming Dai; Keith W Pratz; Allan D Hess; B Douglas Smith; Judith E Karp; Andrea E Wahner Hendrickson; Martin E Fernandez-Zapico; Scott H Kaufmann
Journal:  Blood       Date:  2016-02-25       Impact factor: 22.113

Review 6.  At the crossroads of polarity, proliferation and apoptosis: the use of Drosophila to unravel the multifaceted role of endocytosis in tumor suppression.

Authors:  Thomas Vaccari; David Bilder
Journal:  Mol Oncol       Date:  2009-06-06       Impact factor: 6.603

7.  The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.

Authors:  Lili Shu; Peter J Houghton
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

8.  Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways.

Authors:  Chong Xu; Chunxiao Liu; Lei Liu; Ruijie Zhang; Hai Zhang; Sujuan Chen; Yan Luo; Long Chen; Shile Huang
Journal:  Neuropharmacology       Date:  2015-05-19       Impact factor: 5.250

9.  Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer.

Authors:  Teresa Golden; Ileana V Aragon; Beth Rutland; J Allan Tucker; Lalita A Shevde; Rajeev S Samant; Guofei Zhou; Lauren Amable; Danalea Skarra; Richard E Honkanen
Journal:  Biochim Biophys Acta       Date:  2008-01-26

10.  Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway.

Authors:  Lei Liu; Long Chen; Yan Luo; Wenxing Chen; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Shile Huang
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.